2-tert-butyl-4-quinone has been researched along with 2,5-di-tert-butylbenzoquinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horrocks, P; Johnson-Ajinwo, OR; Li, WW; Mbye, H; Richardson, A; Ullah, I | 1 |
| Calil, FA; Castilho, MS; Chiappetta, ERC; David, JS; Emery, FS; Fumagalli, F; Leite, FHA; Mello, RB; Nonato, MC | 1 |
2 other study(ies) available for 2-tert-butyl-4-quinone and 2,5-di-tert-butylbenzoquinone
| Article | Year |
|---|---|
The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents.
Topics: Antimalarials; Antineoplastic Agents; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Malaria, Falciparum; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship | 2018 |
Ligand-based design, synthesis and biochemical evaluation of potent and selective inhibitors of Schistosoma mansoni dihydroorotate dehydrogenase.
Topics: Animals; Anthelmintics; Dihydroorotate Dehydrogenase; Drug Design; Humans; Ligands; Oxidoreductases Acting on CH-CH Group Donors; Quinones; Schistosoma mansoni; Schistosomiasis mansoni; Structure-Activity Relationship | 2019 |